|
|
|
Insider
Information: |
Ruegg Curtis |
Relationship: |
EVP, Technical Operati... |
City: |
Newark |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
23,944 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$71,114 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
23,944 |
|
|
Total
Value |
$71,114 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Revance Therapeutics, Inc. |
RVNC |
EVP, Technical Operati... |
2016-06-13 |
23,944 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech OperationsOff |
|
2014-02-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,606 |
|
- |
|
RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
|
2014-05-19 |
4 |
A |
$32.22 |
$338,310 |
D/D |
10,500 |
14,106 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
|
2014-09-17 |
4 |
OE |
$2.55 |
$2,963 |
D/D |
1,162 |
15,268 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
|
2014-09-17 |
4 |
AS |
$20.50 |
$41,098 |
D/D |
(2,000) |
13,268 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
|
2014-10-17 |
4 |
OE |
$2.55 |
$3,825 |
D/D |
1,500 |
14,768 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
|
2014-10-17 |
4 |
AS |
$18.50 |
$27,839 |
D/D |
(1,500) |
13,268 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
|
2014-10-28 |
4 |
AS |
$20.00 |
$10,000 |
D/D |
(500) |
13,268 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
|
2014-10-28 |
4 |
OE |
$2.55 |
$1,275 |
D/D |
500 |
13,768 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
|
2014-11-18 |
4 |
OE |
$2.55 |
$2,550 |
D/D |
1,000 |
15,106 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
|
2014-11-18 |
4 |
AS |
$16.00 |
$16,000 |
D/D |
(1,000) |
14,106 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
|
2014-12-09 |
4 |
OE |
$2.55 |
$1,275 |
D/D |
500 |
14,606 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
|
2014-12-09 |
4 |
AS |
$18.00 |
$9,000 |
D/D |
(500) |
14,106 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
|
2014-12-17 |
4 |
OE |
$2.55 |
$2,550 |
D/D |
1,000 |
15,106 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
|
2014-12-17 |
4 |
AS |
$16.45 |
$16,450 |
D/D |
(1,000) |
14,106 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
|
2015-01-09 |
4 |
AS |
$18.00 |
$9,000 |
D/D |
(500) |
14,106 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
|
2015-01-09 |
4 |
OE |
$2.55 |
$1,275 |
D/D |
500 |
14,606 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
|
2015-01-20 |
4 |
OE |
$2.55 |
$2,550 |
D/D |
1,000 |
15,106 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
|
2015-01-20 |
4 |
AS |
$17.25 |
$17,250 |
D/D |
(1,000) |
14,106 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
EVP R&D and Tech Operations |
|
2015-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
5,231 |
19,337 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
EVP, Technical Operations |
|
2015-02-17 |
4 |
OE |
$2.55 |
$5,912 |
D/D |
1,000 |
20,337 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
EVP, Technical Operations |
|
2015-02-17 |
4 |
AS |
$16.80 |
$16,800 |
D/D |
(1,000) |
19,337 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
EVP, Technical Operations |
|
2015-03-09 |
4 |
AS |
$18.00 |
$9,000 |
D/D |
(500) |
19,337 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
EVP, Technical Operations |
|
2015-03-09 |
4 |
OE |
$6.60 |
$3,300 |
D/D |
500 |
19,837 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
EVP, Technical Operations |
|
2015-03-17 |
4 |
OE |
$6.60 |
$9,900 |
D/D |
1,500 |
20,837 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
EVP, Technical Operations |
|
2015-03-17 |
4 |
AS |
$18.61 |
$27,915 |
D/D |
(1,500) |
19,337 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|